glucose, (beta-d)-isomer has been researched along with Pulmonary Hypertension in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flynn, JT; Gee, MH; Havill, AM; Perkowski, SZ | 1 |
| Cheung, H; Driedger, AA; Finley, RJ; Judges, D; Sharkey, P; Sibbald, WJ | 1 |
| Haferkamp, O; Kleeberg, S; Rödel, G; Seibold, H; Stauch, M | 1 |
| McDonald, JW; Smallbone, BW; Taylor, NE | 1 |
| Baranowski, RL; Cheung, AK; Wayman, AL | 1 |
| Flynn, JT; Gee, MH; Perkowski, SZ; Tahamont, MV; Wasserman, MA | 1 |
| Davies, BJ; McDonald, JW; Noulty, EJ; Pisters, LL; Smallbone, BW; Taylor, NE | 1 |
| Flynn, JT; Gee, MH; Perkowski, SZ; Tahamont, MV | 1 |
| Dai, C; Fang, J; Huang, H; Kong, B; Qin, T; Shuai, W; Xiao, Z | 1 |
| Fu, Q; He, J; Li, M; Peng, J; Tan, S; Tang, M; Tang, Y; Xie, W; Xu, X; Zhang, Q; Zhang, Y; Zheng, Z; Zhu, T | 1 |
| Han, H; He, M; Hu, S; Kong, H; Tan, Q; Wang, H; Wang, J; Wang, Y; Wu, X; Xie, W; Xu, J; Yang, M; Yu, M | 1 |
| Cai, H; Cai, X; Chen, M; Chen, Y; Ding, C; Guo, R; Huang, X; Wang, L; Xu, X; Yao, D; Yu, X; Zou, L | 1 |
| Freischmidt, A; Heilmann, J; Kelber, O; Koptina, A; Müller, J; Sadeghlar, F; Ulrich-Merzenich, G; Wagner, H; Zeitler, H | 1 |
| Hu, N; Jiang, XX; Li, B; Li, J; Miao, Q; Miao, S; Shi, XP; Wang, SW; Ye, MX; Zhang, J; Zhang, S | 1 |
| Baron, M; Dupuis, J; Giovinazzo, M; Hirsch, AM; Langleben, D; Langleben, I; Senécal, JL | 1 |
15 other study(ies) available for glucose, (beta-d)-isomer and Pulmonary Hypertension
| Article | Year |
|---|---|
Role of prostaglandins and leukotrienes in complement-initiated lung vascular injury.
Topics: Animals; Catechols; Complement Activation; Epoprostenol; Hypertension, Pulmonary; Hypoxia; Leukocytes; Leukotriene B4; Masoprocol; Meclofenamic Acid; ortho-Aminobenzoates; Oxygenases; Prostaglandins; Pulmonary Circulation; Sheep; Zymosan | 1983 |
The effect of an infusion of zymosan-activated plasma on hemodynamic and pulmonary function in sheep.
Topics: Animals; Cardiac Output; Central Venous Pressure; Complement C5; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Infusions, Parenteral; Leukocyte Count; Lung; Lymph; Neutrophils; Osmotic Pressure; Oxygen Consumption; Pulmonary Wedge Pressure; Respiratory Function Tests; Sheep; Zymosan | 1984 |
Neutrophilic migration through capillarylike micropores: influence of pulmonary passage.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Angina Pectoris; Cell Movement; Chemotaxis, Leukocyte; Female; Heart Valve Diseases; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Microcirculation; Middle Aged; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pulmonary Artery; Pulmonary Circulation; Zymosan | 1993 |
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan | 1987 |
The role of thromboxane in cuprophan-induced pulmonary hypertension.
Topics: Animals; Cellulose; Female; Hypertension, Pulmonary; Male; Methacrylates; Swine; Thromboxanes; Zymosan | 1987 |
Thromboxane as a mediator of pulmonary dysfunction during intravascular complement activation in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Capillary Permeability; Complement Activation; Hypertension, Pulmonary; Hypoxia; Imidazoles; Leukocytes; Lung Diseases; Plasma; Pulmonary Circulation; Sheep; Sulfonamides; Thromboxane A2; Zymosan | 1986 |
Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Complement Activation; Female; Hypertension, Pulmonary; Hypoxia; Neutropenia; Sheep; Thromboxane B2; Verapamil; Zymosan | 1986 |
Arachidonic acid metabolites as mediators of lung injury during intravascular complement activation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Blood Gas Analysis; Cell Adhesion; Complement Activation; Hypertension, Pulmonary; Leukocytes; Lung; Prostaglandin-Endoperoxide Synthases; Sheep; Thromboxane B2; Zymosan | 1985 |
Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2022 |
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Glucosides; Humans; Hypertension, Pulmonary; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Sildenafil Citrate; Vascular Remodeling | 2022 |
Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Glucosides; Hypertension, Pulmonary; MAP Kinase Kinase Kinases; Monocrotaline; Monoterpenes; NF-kappa B; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats | 2022 |
Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
Topics: Animals; Apoptosis; Disease Models, Animal; Gene Expression; Glucosides; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Mice; Mitochondria; Myocytes, Smooth Muscle; Phenols; Pulmonary Artery; Receptor, Adenosine A2A; RNA, Messenger; Signal Transduction; Vascular Remodeling | 2015 |
Prediction of adverse events by in vivo gene expression profiling exemplified for phytopharmaceuticals containing salicylates and the antidepressant imipramine.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzyl Alcohols; Chemical and Drug Induced Liver Injury; Ethanol; Gene Expression Profiling; Gene Expression Regulation; Glucosides; Heart Diseases; Hypertension, Pulmonary; Imipramine; Male; Nephritis; Phytotherapy; Plant Bark; Plant Extracts; Rats; Rats, Sprague-Dawley; Salicylates | 2012 |
Polydatin attenuates hypoxic pulmonary hypertension and reverses remodeling through protein kinase C mechanisms.
Topics: Angiotensin II; Animals; Endothelins; Glucosides; Hypertension, Pulmonary; Hypoxia; Male; Nitric Oxide; Phorbol Esters; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Stilbenes; Vascular Remodeling | 2012 |
Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension.
Topics: Cyclohexanones; Endothelin-1; Endothelium, Vascular; Female; Glucosides; Humans; Hypertension, Pulmonary; Indicator Dilution Techniques; Male; Microcirculation; Pulmonary Diffusing Capacity; Thermodilution | 2006 |